Time-controlled oral delivery systems for colon targeting

A review. In recent years, many research efforts have been spent in the achievement of selective delivery of drugs into the colon following oral administration. Indeed, colonic release is regarded as a beneficial approach to the pharmacol. treatment or prevention of widespread large bowel pathologies, such as inflammatory bowel disease and adenocarcinoma. In addn., it is extensively explored as a potential means of enhancing the oral bioavailability of peptides, proteins and other biotechnol. mols., which are known to be less prone to enzymic degrdn. in the large, rather than in the small, intestine. Based on these premises, several formulation strategies have been attempted in pursuit of colonic release, chiefly including microflora-, pH-, pressure- and time-dependent delivery technologies. In particular, this review is focused on the main design features and release performances of time-controlled devices, which rely on the relative constancy that is obsd. in the small intestinal transit time of dosage forms